Rocket Pharmaceuticals (RCKT) Shares Issued (2014 - 2026)
Rocket Pharmaceuticals (RCKT) posted Shares Issued of $10.0 million for Q1 2026, down 17.63% sequentially from $12.2 million in Q4 2025, and down 27.78% YoY from $13.9 million in Q1 2025.
Rocket Pharmaceuticals (RCKT) Shares Issued (2014 - 2026) Analysis & Trends
Rocket Pharmaceuticals has reported Shares Issued for 13 years, with the latest figure at $10.0 million in Q1 2026.
- Quarterly Shares Issued fell 27.78% year-over-year to $10.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.0 million (down 27.78% YoY) and the FY2025 annual result came in at $12.2 million, down 24.19% from the prior year.
- Shares Issued slipped to $10.0 million in Q1 2026 per RCKT's latest filing, from $12.2 million in the prior quarter.
- Over five years, Shares Issued peaked at $16.1 million in Q3 2024 and troughed at $9.1 million in Q1 2022.
- A 5-year average of $13.0 million and a median of $13.1 million in 2022 frame the typical range for Shares Issued.
- The sharpest annual moves came in 2023 and 2026: Shares Issued surged 60.28% in 2023, then dropped 27.78% in 2026.
- Over 5 years, Shares Issued stood at $13.1 million in 2022, then gained by 13.13% to $14.9 million in 2023, then grew by 7.94% to $16.0 million in 2024, then declined by 24.19% to $12.2 million in 2025, then dropped by 17.63% to $10.0 million in 2026.
- According to Business Quant data, Shares Issued over the past three periods registered $10.0 million, $12.2 million, and $13.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 18.36 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Rocket Pharmaceuticals | 380.92 Mn | 380.92 Mn | - | 13.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.47 Mn |
| Jun 30, 2026 | 13.47 Mn |
| Mar 31, 2026 | 10.02 Mn |
| Mar 31, 2026 | 10.02 Mn |
| Dec 31, 2025 | 12.16 Mn |
| Dec 31, 2025 | 12.16 Mn |
| Sep 30, 2025 | 13.78 Mn |
| Sep 30, 2025 | 13.78 Mn |
| Jun 30, 2025 | 13.43 Mn |
| Jun 30, 2025 | 13.43 Mn |
| Mar 31, 2025 | 13.87 Mn |
| Mar 31, 2025 | 13.87 Mn |
| Dec 31, 2024 | 16.04 Mn |
| Dec 31, 2024 | 16.04 Mn |
| Sep 30, 2024 | 16.15 Mn |
| Sep 30, 2024 | 16.15 Mn |
| Jun 30, 2024 | 12.74 Mn |
| Jun 30, 2024 | 12.74 Mn |
| Mar 31, 2024 | 12.35 Mn |
| Mar 31, 2024 | 12.35 Mn |